Patients with failure of infarct-related artery recanalization after thrombolytic therapy have a poor clinical outcome. These patients have been considered for rescue angioplasty 90 min after thrombolytic therapy at the time of emergency catheterization in the course of five Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trials. The outcome of 776 patients with patent infarct-related vessels after emergency catheterization was analyzed–607 with thrombolysis-mediated patency of the infarct-related vessel and 169 with patency achieved by angioplasty.Baseline characteristics of the thrombolysis and angioplasty patency groups were similar except for a higher acute left ventricular ejection fraction (51.3% versus 48.2%) in the thro...
AbstractIn the first three phases of Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) mu...
Percutaneous coronary intervention is not successful in all patients whose acute myocardial infarcti...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infar...
Patients with failure of infarct-related artery recanalization after thrombolytic therapy have a poo...
BACKGROUND: The appropriate treatment for patients in whom reperfusion fails to occur after thrombol...
textabstractA total of 533 patients with acute myocardial infarction of less than 4-h duration were ...
AbstractThe influence of infarct location on arterial patency, left ventricular function and mortali...
AbstractObjectives. We sought to assess the angiographic outcome, complication rates and clinical fe...
Reperfusion therapy has been clearly shown to decrease the early mortality after acute myocardial in...
The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial was a randomized, multicenter...
AbstractThe in-hospital course of 500 consecutive patients treated with coronary angioplasty for acu...
Percutaneous coronary intervention is not successful in all patients whose acute myocardial infarcti...
textabstractThe comparative efficacy of thrombolytic drugs and primary angioplasty for acute myocard...
Background Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarctio...
Background: Primary angioplasty is superior to intravenous thrombolysis as reperfusion therapy for ...
AbstractIn the first three phases of Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) mu...
Percutaneous coronary intervention is not successful in all patients whose acute myocardial infarcti...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infar...
Patients with failure of infarct-related artery recanalization after thrombolytic therapy have a poo...
BACKGROUND: The appropriate treatment for patients in whom reperfusion fails to occur after thrombol...
textabstractA total of 533 patients with acute myocardial infarction of less than 4-h duration were ...
AbstractThe influence of infarct location on arterial patency, left ventricular function and mortali...
AbstractObjectives. We sought to assess the angiographic outcome, complication rates and clinical fe...
Reperfusion therapy has been clearly shown to decrease the early mortality after acute myocardial in...
The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial was a randomized, multicenter...
AbstractThe in-hospital course of 500 consecutive patients treated with coronary angioplasty for acu...
Percutaneous coronary intervention is not successful in all patients whose acute myocardial infarcti...
textabstractThe comparative efficacy of thrombolytic drugs and primary angioplasty for acute myocard...
Background Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarctio...
Background: Primary angioplasty is superior to intravenous thrombolysis as reperfusion therapy for ...
AbstractIn the first three phases of Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) mu...
Percutaneous coronary intervention is not successful in all patients whose acute myocardial infarcti...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infar...